From “good news” to “failure”: how French participants experienced an HIV remission trial
Young people want research to focus on a cure for HIV, sharing their status and U=U
New HIV drugs should be classed as inferior if they carry a higher risk of resistance
How do participants feel about analytical treatment interruptions in HIV cure-directed trials?
“We went back to the community and told them it didn’t work” – lessons learned from a trial of youth-friendly health services
How can HIV cure trials increase racial and gender diversity and equity?
Not counted: clinical trials of new HIV treatments are failing women
Study participants and their partners need reassurance when treatment interruption required in quest for an HIV cure
Merck restarts islatravir HIV treatment studies, but abandons monthly PrEP
